Skip to main content
Home » Reports » Healthcare » Cerebral Spinal Fluid (CSF) Management Market
ReesrachMoz Brochure Icon

Global Cerebral Spinal Fluid (CSF) Management Market Analysis and Forecast 2022-2028

Report ID:683Healthcare255 pages

Cerebral Spinal Fluid (CSF) Management Market Statistics

The global cerebral spinal fluid management market is predicted to observe steady growth during the forecast period between 2022 to 2028.

The market is expected to witness growth at a CAGR of 5.3% and is projected to reach the estimated value of USD 2.61bn during the forecast period.

The covid pandemic had a negative impact on the cerebral spinal fluid management market as the surgeries, and treatment of tumours got delayed in order to prioritize covid cases which were the need of the hour.

However, the industry is regaining its market presence with resilience and is expected to grow in the following years.

The rising number of infectious diseases in the spinal and brain are expected to drive the global cerebral spinal fluid management market in the coming years.

Drivers And Restraints

The booming use of cerebral spinal fluid tests to diagnose conditions such as meningitis is projected to boost sales in the cerebral spinal fluid management market.

The growing cases of congenital hydrocephalus among infants is predicted to strengthen the global cerebral spinal fluid management market during the forecast period.

Further, cases such as brain tumours are expected to drive the demand for cerebral spinal fluid management market in the coming years.

The growing geriatric population across the globe is expected to amplify the sales of cerebral spinal fluid management market in the next few years.

However, the lack of trained professionals and side effects associated with cerebral spinal fluid is anticipated to restraint the market during the forecast period. Also, the high cost of surgeries is predicted to hinder the growth opportunities in the market.

Despite the restraint, the strong demand for cerebral spinal fluid management market is also expected to come from chronic rhinosinusitis, thus pushing the market towards expansion during the forecast period.

Global Cerebral Spinal Fluid CSF Management Market Share By Region Type

Opportunities And Trends

Rising investment in research and development is expected to drive the growth potentials for the global cerebral spinal fluid management.

The ongoing development to improve the safety factors associated with the use of cerebral spinal fluid is projected to intensify the growth opportunities for the market in coming years.

The increasing trend of availability of better healthcare facilities is expected to nudge the cerebral spinal fluid management market to expand in the forecast years.

The grants for research in neuromodulation cures and therapies for the prognosis of nervous system disorders are expected to boost the market in the forthcoming years.

New and novel insights from cellular and molecular biology along with neuroimaging are challenging the conventional concepts of cerebral spinal fluid management is expected to drive the growth opportunities in the global market.

The increase in the number of brain surgeries is expected to augment the market during the forecast period.

The rise in a number of traumatic brain injuries is predicted to amplify the growth in the growth of the cerebral spinal fluid management market in the coming years.

Product Segmentation Overview

On the basis of product types, the cerebral spinal fluid management market is bifurcated into – shunts and drainage.

Of these two, the shunts segment is projected to thrive and hold a lion’s share in the global cerebral spinal fluid management market.

The growth of shunt segment is attributable to its ability to drain the excess fluid from the brain and pass it on to the abdomen area where it gets absorbed.

On the basis of applications, the global cerebral spinal fluid management market is segmented into – adults, paediatric, and geriatric

Of all three of these, paediatrics is expected to hold the largest share during the forecast period due to increasing cases of congenital hydrocephalus in infants.

Simultaneously, the geriatric segment is also anticipated to witness growth in the cerebral spinal fluid management. The growth could be due to increase in antinuclear antibodies, an autoimmune disorder seen in senior citizens. Also, the sudden outbreak of malignant gliomas, a common type of brain tumor may widen the market for cerebral spinal fluid management market during the forecast period.

Further, in terms of the end-users, the cerebral spinal fluid management market is bifurcated into – hospitals, clinics, neurological centres, and ambulatory surgical centres

Among all these, the hospital segment is expected to hold the highest share in the market during the forecast period, the growth can be attributed to improved health infrastructure and availability of skilled professionals and other facilities under one roof.

Regional Overview

In terms of regional growth in the global cerebral spinal fluid management market, Asia Pacific is expected to hold a major share, owing to the growing geriatric population and the availability of experienced neurosurgeons.

The growth in this region is also attributable to increasing medical tourism in the region. Also, the transformational shift in neurological treatment is expected to boost the growth in this region.

Alternatively, the increasing cases of encephalitis in Japan is projected to drive the growth in the region in the global cerebral spinal fluid management market during the forecast years.

Competitive Landscape

The cerebral spinal fluid management market is competitive in nature due to the presence of many players.

These players are focusing on new product launches, business expansion, mergers, collaborations, acquisitions, etc. in order to intensify their market presence and increase their profitability during the forecast period.

Some of the current players in the global cerebral spinal fluid management market include-

  • Spiegelberg
  • Integra Life Sciences
  • Sophysa
  • BeckerSmith Medical
  • Dispomedica
  • DePuy Synthes Companies (Johnson & Johnson)
  • BeckerSmith Medical

Product Disposition (Revenue in USD million)

  • CSF Shunts
  • Adjustable CSF Shunts
  • Fixed CSF Shunts
  • CSF Drainage Systems
  • Lumbar Drainage System
  • Ventricular Drainage System

Application Disposition (Revenue in USD million)

  • Pediatric
  • Adult
  • Geriatric

End-User Disposition (Revenue in USD million)

  • Ambulatory Surgical Centers
  • Clinics
  • Hospitals
  • Neurological Centers

Regional Disposition

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa (MEA)

Some Frequently Asked Questions- 

  1. How significantly the cerebral spinal fluid management market is expected to grow?
  2. How did covid pandemic impact the cerebral spinal fluid management market?
  3. Which product and application segment are expected to thrive and what are the growth opportunities in these segments?
  4. Which region is expected to grow remarkably during the forecast period and why?
  5. What competitive strategies needs to be taken into consideration while trying to expand the market presence?
  6. What are the challenges in the global cerebral spinal fluid management market?
  7. What are the trends in the cerebral spinal fluid management market?
  8. What factors could lead towards growth opportunities in the future?
  9. What are the major determinants of the growth in the global cerebral spinal fluid management market during the forecast period?

Table of Content

1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations

2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations

3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Supply Chain Analysis
3.6. Investment Feasibility Matrix
3.7. Value Chain Analysis
3.8. PESTLE and Porter’s Analysis
3.9. Regulatory Landscape
3.9.1. By Key Regions
3.9.2. By Key Countries
3.10. Regional Parent Market Outlook
3.11. Production and Consumption Statistics
3.12. Import and Export Statistics

4. Global Cerebral Spinal Fluid (CSF) Management Market Analysis 2017-2021 and Forecast, 2022-2032
4.1. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis, 2017-2021
4.2. Current and Future Market Size Value (US$ Mn) & Volume (Units) Projections, 2022-2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis

5. Global Cerebral Spinal Fluid (CSF) Management Market Analysis 2017-2021 and Forecast 2022-2032, By Product Disposition (Revenue in USD million)
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By Product Disposition (Revenue in USD million), 2017-2021
5.3. Current and Future Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By Product Disposition (Revenue in USD million), 2022-2032
5.3.1. CSF Shunts
5.3.2. Adjustable CSF Shunts
5.3.3. Fixed CSF Shunts
5.3.4. CSF Drainage Systems
5.3.5. Lumbar Drainage System
5.3.6. Ventricular Drainage System
5.4. Y-o-Y Growth Trend Analysis By Product Disposition (Revenue in USD million), 2017-2021
5.5. Absolute $ Opportunity Analysis By Product Disposition (Revenue in USD million), 2022-2032

6. Global Cerebral Spinal Fluid (CSF) Management Market Analysis 2017-2021 and Forecast 2022-2032, By Application Disposition
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By Application Disposition, 2017-2021
6.3. Current and Future Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By Application Disposition, 2022-2032
6.3.1. Pediatric
6.3.2. Adult
6.3.3. Geriatric
6.4. Y-o-Y Growth Trend Analysis By Application Disposition, 2017-2021
6.5. Absolute $ Opportunity Analysis By Application Disposition, 2022-2032

7. Global Cerebral Spinal Fluid (CSF) Management Market Analysis 2017-2021 and Forecast 2022-2032, By End User Disposition
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By End User Disposition, 2017-2021
7.3. Current and Future Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By End User Disposition, 2022-2032
7.3.1. Ambulatory Surgical Centers
7.3.2. Clinics
7.3.3. Hospitals
7.3.4. Neurological Centers
7.4. Y-o-Y Growth Trend Analysis By End User Disposition, 2017-2021
7.5. Absolute $ Opportunity Analysis By End User Disposition, 2022-2032

8. Global Cerebral Spinal Fluid (CSF) Management Market Analysis 2017-2021 and Forecast 2022-2032, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By Region, 2017-2021
8.3. Current Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By Region, 2022-2032
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. East Asia
8.3.5. South Asia
8.3.6. Oceania
8.3.7. MEA
8.4. Market Attractiveness Analysis By Region

9. North America Cerebral Spinal Fluid (CSF) Management Market Analysis 2017-2021 and Forecast 2022-2032, By Country
9.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021
9.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032
9.2.1. By Country
9.2.1.1. U.S.
9.2.1.2. Canada
9.2.2. By Product Disposition (Revenue in USD million)
9.2.3. By Application Disposition
9.2.4. By End User Disposition
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Product Disposition (Revenue in USD million)
9.3.3. By Application Disposition
9.3.4. By End User Disposition
9.4. Key Takeaways

10. Latin America Cerebral Spinal Fluid (CSF) Management Market Analysis 2017-2021 and Forecast 2022-2032, By Country
10.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021
10.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032
10.2.1. By Country
10.2.1.1. Brazil
10.2.1.2. Mexico
10.2.1.3. Argentina
10.2.1.4. Chile
10.2.1.5. Peru
10.2.1.6. Rest of Latin America
10.2.2. By Product Disposition (Revenue in USD million)
10.2.3. By Application Disposition
10.2.4. By End User Disposition
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Product Disposition (Revenue in USD million)
10.3.3. By Application Disposition
10.3.4. By End User Disposition
10.4. Key Takeaways

11. Europe Cerebral Spinal Fluid (CSF) Management Market Analysis 2017-2021 and Forecast 2022-2032, By Country
11.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021
11.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032
11.2.1. By Country
11.2.1.1. Germany
11.2.1.2. Italy
11.2.1.3. France
11.2.1.4. U.K.
11.2.1.5. Spain
11.2.1.6. Russia
11.2.1.7. BENELUX
11.2.1.8. Rest of Europe
11.2.2. By Product Disposition (Revenue in USD million)
11.2.3. By Application Disposition
11.2.4. By End User Disposition
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Product Disposition (Revenue in USD million)
11.3.3. By Application Disposition
11.3.4. By End User Disposition
11.4. Key Takeaways

12. East Asia Cerebral Spinal Fluid (CSF) Management Market Analysis 2017-2021 and Forecast 2022-2032, By Country
12.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021
12.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032
12.2.1. By Country
12.2.1.1. China
12.2.1.2. Japan
12.2.1.3. South Korea
12.2.2. By Product Disposition (Revenue in USD million)
12.2.3. By Application Disposition
12.2.4. By End User Disposition
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Product Disposition (Revenue in USD million)
12.3.3. By Application Disposition
12.3.4. By End User Disposition
12.4. Key Takeaways

13. South Asia Cerebral Spinal Fluid (CSF) Management Market Analysis 2017-2021 and Forecast 2022-2032, By Country
13.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021
13.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032
13.2.1. By Country
13.2.1.1. India
13.2.1.2. Thailand
13.2.1.3. Malaysia
13.2.1.4. Indonesia
13.2.1.5. Rest of South Asia
13.2.2. By Product Disposition (Revenue in USD million)
13.2.3. By Application Disposition
13.2.4. By End User Disposition
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Product Disposition (Revenue in USD million)
13.3.3. By Application Disposition
13.3.4. By End User Disposition
13.4. Key Takeaways

14. Oceania Cerebral Spinal Fluid (CSF) Management Market Analysis 2017-2021 and Forecast 2022-2032, By Country
14.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021
14.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032
14.2.1. By Country
14.2.1.1. Australia
14.2.1.2. New Zealand
14.2.2. By Product Disposition (Revenue in USD million)
14.2.3. By Application Disposition
14.2.4. By End User Disposition
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Product Disposition (Revenue in USD million)
14.3.3. By Application Disposition
14.3.4. By End User Disposition
14.4. Key Takeaways

15. MEA Cerebral Spinal Fluid (CSF) Management Market Analysis 2017-2021 and Forecast 2022-2032, By Country
15.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021
15.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032
15.2.1. By Country
15.2.1.1. GCC
15.2.1.2. Rest of MEA
15.2.2. By Product Disposition (Revenue in USD million)
15.2.3. By Application Disposition
15.2.4. By End User Disposition
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Product Disposition (Revenue in USD million)
15.3.3. By Application Disposition
15.3.4. By End User Disposition
15.4. Key Takeaways

16. Key Countries Cerebral Spinal Fluid (CSF) Management Market Analysis
16.1. U.S.
16.1.1. Pricing Analysis
16.1.2. Market Share Analysis, 2021
16.1.2.1. By Product Disposition (Revenue in USD million)
16.1.2.2. By Application Disposition
16.1.2.3. By End User Disposition
16.2. Canada
16.2.1. Pricing Analysis
16.2.2. Market Share Analysis, 2021
16.2.2.1. By Product Disposition (Revenue in USD million)
16.2.2.2. By Application Disposition
16.2.2.3. By End User Disposition
16.3. Brazil
16.3.1. Pricing Analysis
16.3.2. Market Share Analysis, 2021
16.3.2.1. By Product Disposition (Revenue in USD million)
16.3.2.2. By Application Disposition
16.3.2.3. By End User Disposition
16.4. Mexico
16.4.1. Pricing Analysis
16.4.2. Market Share Analysis, 2021
16.4.2.1. By Product Disposition (Revenue in USD million)
16.4.2.2. By Application Disposition
16.4.2.3. By End User Disposition
16.5. Argentina
16.5.1. Pricing Analysis
16.5.2. Market Share Analysis, 2021
16.5.2.1. By Product Disposition (Revenue in USD million)
16.5.2.2. By Application Disposition
16.5.2.3. By End User Disposition

17. Market Structure Analysis
17.1. Competition Dashboard
17.2. Competition Benchmarking
17.3. Market Share Analysis of Top Players
17.3.1.  By Regional
17.3.2.  By Product Disposition (Revenue in USD million)
17.3.3.  By Application Disposition
17.3.4.  By End User Disposition

18. Competition Analysis
18.1. Competition Deep Dive
18.1.1. Spiegelberg
18.1.1.1. Overview
18.1.1.2. Product Portfolio
18.1.1.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
18.1.1.4. Sales Footprint
18.1.1.5. Strategy Overview
18.1.1.5.1. Marketing Strategy
18.1.1.5.2. Product Strategy
18.1.1.5.3. Channel Strategy
18.1.2. Integra Life Sciences
18.1.2.1. Overview
18.1.2.2. Product Portfolio
18.1.2.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
18.1.2.4. Sales Footprint
18.1.2.5. Strategy Overview
18.1.2.5.1. Marketing Strategy
18.1.2.5.2. Product Strategy
18.1.2.5.3. Channel Strategy
18.1.3. Sophysa
18.1.3.1. Overview
18.1.3.2. Product Portfolio
18.1.3.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
18.1.3.4. Sales Footprint
18.1.3.5. Strategy Overview
18.1.3.5.1. Marketing Strategy
18.1.3.5.2. Product Strategy
18.1.3.5.3. Channel Strategy
18.1.4. BeckerSmith Medical
18.1.4.1. Overview
18.1.4.2. Product Portfolio
18.1.4.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
18.1.4.4. Sales Footprint
18.1.4.5. Strategy Overview
18.1.4.5.1. Marketing Strategy
18.1.4.5.2. Product Strategy
18.1.4.5.3. Channel Strategy
18.1.5. Dispomedica
18.1.5.1. Overview
18.1.5.2. Product Portfolio
18.1.5.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
18.1.5.4. Sales Footprint
18.1.5.5. Strategy Overview
18.1.5.5.1. Marketing Strategy
18.1.5.5.2. Product Strategy
18.1.5.5.3. Channel Strategy
18.1.6. DePuy Synthes Companies (Johnson & Johnson)
18.1.6.1. Overview
18.1.6.2. Product Portfolio
18.1.6.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
18.1.6.4. Sales Footprint
18.1.6.5. Strategy Overview
18.1.6.5.1. Marketing Strategy
18.1.6.5.2. Product Strategy
18.1.6.5.3. Channel Strategy
18.1.7. BeckerSmith Medical
18.1.7.1. Overview
18.1.7.2. Product Portfolio
18.1.7.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
18.1.7.4. Sales Footprint
18.1.7.5. Strategy Overview
18.1.7.5.1. Marketing Strategy
18.1.7.5.2. Product Strategy
18.1.7.5.3. Channel Strategy

19. Assumptions & Acronyms Used

20. Research Methodology

Request Free Sample

Hidden
Company logos Strips